These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34077245)

  • 21. Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.
    Huy NQ; Lucie C; Hoa TTT; Hung NV; Lan NTN; Son NT; Nhung NV; Anh DD; Anne-Laure B; Van Anh NT
    Emerg Microbes Infect; 2017 Oct; 6(10):e86. PubMed ID: 29018250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects.
    Wu X; Lu W; Shao Y; Song H; Li G; Li Y; Zhu L; Chen C
    Infect Genet Evol; 2019 Aug; 72():147-150. PubMed ID: 30447296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping].
    Özgür D; Tezcan Ülger S; Kayar MB; Biçmen C; Aslantürk A; Ülger M; Aslan G
    Mikrobiyol Bul; 2022 Apr; 56(2):191-205. PubMed ID: 35477224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrazinamide Susceptibility and
    Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.
    Werngren J; Sturegård E; Juréen P; Ängeby K; Hoffner S; Schön T
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1253-7. PubMed ID: 22203587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains.
    Sekiguchi J; Nakamura T; Miyoshi-Akiyama T; Kirikae F; Kobayashi I; Augustynowicz-Kopec E; Zwolska Z; Morita K; Suetake T; Yoshida H; Kato S; Mori T; Kirikae T
    J Clin Microbiol; 2007 Sep; 45(9):2802-7. PubMed ID: 17596354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
    BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is sequencing better than phenotypic tests for the detection of pyrazinamide resistance?
    Bouzouita I; Cabibbe AM; Trovato A; Draoui H; Ghariani A; Midouni B; Essalah L; Mehiri E; Cirillo DM; Slim-Saidi L
    Int J Tuberc Lung Dis; 2018 Jun; 22(6):661-666. PubMed ID: 29862951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.
    Morlock GP; Crawford JT; Butler WR; Brim SE; Sikes D; Mazurek GH; Woodley CL; Cooksey RC
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2291-5. PubMed ID: 10952570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.
    Miotto P; Cabibbe AM; Feuerriegel S; Casali N; Drobniewski F; Rodionova Y; Bakonyte D; Stakenas P; Pimkina E; Augustynowicz-Kopeć E; Degano M; Ambrosi A; Hoffner S; Mansjö M; Werngren J; Rüsch-Gerdes S; Niemann S; Cirillo DM
    mBio; 2014 Oct; 5(5):e01819-14. PubMed ID: 25336456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
    Lee KW; Lee JM; Jung KS
    J Korean Med Sci; 2001 Oct; 16(5):537-43. PubMed ID: 11641519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid detection of Mycobacterium tuberculosis and pyrazinamide susceptibility related to pncA mutations in sputum specimens through an integrated gene-to-protein function approach.
    Li H; Chen J; Zhou M; Geng X; Yu J; Wang W; Zhang XE; Wei H
    J Clin Microbiol; 2014 Jan; 52(1):260-7. PubMed ID: 24226918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
    Hong CY; Wang F; Gui J; Liu XL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
    Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.
    Driesen M; Kondo Y; de Jong BC; Torrea G; Asnong S; Desmaretz C; Mostofa KSM; Tahseen S; Whitfield MG; Cirillo DM; Miotto P; Cabibbe AM; Rigouts L
    Clin Microbiol Infect; 2018 Jan; 24(1):60-64. PubMed ID: 28587904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
    Yüksel P; Tansel O
    New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
    Doustdar F; Khosravi AD; Farnia P
    Microb Drug Resist; 2009 Dec; 15(4):251-6. PubMed ID: 19857130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: Identification of a species-specific pncA mutation in "Mycobacterium canettii" and the reliable and rapid predictor of pyrazinamide resistance.
    Somoskovi A; Dormandy J; Parsons LM; Kaswa M; Goh KS; Rastogi N; Salfinger M
    J Clin Microbiol; 2007 Feb; 45(2):595-9. PubMed ID: 17135430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.